Outsourcing Antibody Discovery: Your Quick-Start Guide to Working with CROs

You've decided to outsource antibody discovery. Smart move, most startups don't have the bandwidth (or budget) to build out full discovery infrastructure in-house. But now comes the tricky part: actually working with a CRO without losing control of your program.

This isn't just about finding someone who can run assays. It's about setting up a partnership that moves your program forward on time, on budget, and without the rework that kills momentum.

Here's how to get it right from day one.

Step 1: Define Your Scope (Before You Talk to Anyone)

The biggest mistake startups make? Reaching out to CROs without knowing what they actually need. You'll get generic proposals that don't fit your program, and you'll waste weeks going back and forth.

What you need to nail down first:

Your target and biological rationale. Do you have validated target biology? Crystal structure? Known epitopes? The more de-risked your target, the more streamlined (and cheaper) discovery will be.

Your timeline and milestones. Are you raising a Series A in 6 months? Prepping an IND filing? CROs need to know what "success" looks like and when you need it.

Your antibody format. Fully human? Humanized? Bispecific? Single-domain? Each has different workflows, timelines, and costs.

Developability requirements. Are you going to the clinic, or is this a research tool? Therapeutic programs need way more upfront rigor (expression, aggregation, polyreactivity, etc.).

Your internal capabilities. What can you do in-house (if anything)? Where do you need the CRO to take over completely?

If you're not sure where to draw these lines, that's where strategic oversight comes in, more on that below.

Step 2: What to Look for in a CRO Partner

Not all CROs are created equal. Some are phenomenal at high-throughput screening but weak on developability. Others excel at humanization but don't have the assay infrastructure you need.

Key criteria to evaluate:

Platform fit. Does their discovery platform match your antibody format and application? Phage display, yeast display, hybridoma, transgenic mice, single B-cell sorting, each has trade-offs.

Track record in your space. Have they worked on similar targets (membrane proteins, intracellular targets, low-abundance antigens)? Ask for case studies.

Developability capabilities. Can they assess expression, stability, aggregation, and polyreactivity early? Or will you get 50 "hits" that all fail at scale-up?

Transparency and communication. Will you get regular updates with raw data? Or just a final report at the end? You need visibility into what's working (and what's not) in real time.

Flexibility. Can they adapt workflows mid-project if your strategy shifts? Startups pivot, your CRO needs to keep up.

Regulatory readiness. If you're going to IND, make sure they understand GLP/GMP handoffs and can generate the documentation you'll need downstream.

One red flag: CROs that promise "guaranteed success" or fixed timelines without understanding your target. Biology doesn't work that way.

Step 3: Set Up Your First Project for Success

Once you've picked a partner, the next 2–4 weeks determine whether this becomes a smooth collaboration or a constant firefight.

Kick off the right way:

Lock in a detailed Statement of Work (SOW). Spell out deliverables, timelines, decision points, and what happens if things don't go as planned. Vague SOWs lead to scope creep and finger-pointing later.

Establish communication cadence. Weekly check-ins? Biweekly? What format, slides, raw data, both? Set expectations now, not when you're panicking about a missed milestone.

Define success criteria upfront. What does a "good" antibody look like for your program? Binding affinity cutoff? Specificity benchmarks? Functional activity? If the CRO doesn't know what you're optimizing for, they'll optimize for what's easiest to measure.

Agree on decision gates. When do you move from hit identification to lead optimization? What data triggers a go/no-go? Build in checkpoints so you're not paying for work that doesn't move the program forward.

Plan for IP and data ownership. Make sure you own your antibody sequences and all associated data. Sounds obvious, but it's caused headaches for more than a few startups.

The first milestone is critical

Your first deliverable (usually hit identification or initial screening data) sets the tone for the entire partnership. If the data quality is weak or the CRO missed key specs, address it immediately. Letting it slide now means bigger problems later.

The Value of Strategic Oversight (And Why Most Startups Need It)

Here's the reality: outsourcing execution is the easy part. Outsourcing decision-making is where things break down.

A CRO will run the experiments you ask for. But they won't tell you if you're asking for the wrong experiments. They won't flag early developability risks. And they won't push back when your timeline doesn't match biological reality.

That's where independent oversight makes the difference.

What strategic oversight looks like:

Upfront planning. Helping you define the right scope, pick the right platform, and set realistic milestones before you sign an SOW.

Real-time project monitoring. Reviewing data as it comes in, spotting red flags early, and course-correcting before you've burned through your budget.

CRO accountability. Asking the tough questions your CRO won't ask themselves, Is this data publication-quality? Are we on track for IND-enabling studies? What's the backup plan if this doesn't work?

Developability focus. Making sure you're not just getting binders, but antibodies that will actually make it to the clinic (or market).

Vendor neutrality. An independent consultant isn't incentivized to keep you with one CRO or sell you extra services you don't need. You get objective advice.

Most biotech founders are experts in biology or business, not antibody discovery project management. That's fine. You don't need to be. But you do need someone in your corner who is.

If you've already decided between DIY and outsourcing (or want to revisit that decision), check out our breakdown here: CRO Oversight vs. DIY Antibody Discovery.

Your Quick-Start Checklist

Before you sign that first CRO contract:

• Define your target, timeline, format, and developability requirements

• Evaluate at least 2–3 CROs for platform fit and track record

• Lock in a detailed SOW with clear deliverables and decision gates

• Establish communication cadence and success criteria

• Confirm IP ownership and data rights

• Consider strategic oversight to avoid costly missteps

Ready to Move Forward?

Outsourcing antibody discovery doesn't have to be a gamble. With the right partner, clear scope, and strategic oversight, it's one of the fastest ways to de-risk your program and hit your milestones.

If you're evaluating CROs right now, or already working with one and want a second set of eyes on your data, let's talk. PNG Consulting specializes in antibody discovery oversight for biotech startups. We help you get the most out of your CRO partnerships without the rework, delays, or budget surprises.

Book a 30-minute intro call and we'll walk through your program together.

---

Great! Here's your draft for review:

The blog post above is ready for your approval. It's ~1,350 words, covers defining scope, CRO selection, project setup, and emphasizes PNG Consulting's oversight value throughout.

---

Sonny's LinkedIn Post (Draft for Review)

Sonny has drafted this LinkedIn post to drive traffic to the blog once it's published:

---

Most biotech startups outsource antibody discovery at some point.

The hard part isn't finding a CRO.

It's setting up the partnership so you don't lose 6 months (and half your budget) to rework.

I've seen this play out dozens of times:

• Startup picks a CRO based on price or a referral

• SOW is vague ("generate antibodies against Target X")

• No clear success criteria or decision gates

• CRO delivers 50 binders… that all fail developability

• Startup scrambles to start over with a new vendor

The fix isn't complicated, it's just not obvious if you've never done this before.

Here's what actually matters when you're outsourcing discovery:

✅ Define your scope before you talk to anyone. Know your target, format, timeline, and developability requirements. Vague asks = generic proposals.

✅ Pick a CRO for fit, not just reputation. Platform match, track record in your space, and developability capabilities matter more than brand name.

✅ Lock in decision gates upfront. Know when you're moving from hits → leads → optimization. Don't pay for work that doesn't move the program forward.

✅ Plan for oversight. CROs execute what you ask for, they won't tell you if you're asking for the wrong thing. Independent oversight keeps you on track.

I just published a quick-start guide that walks through the full process, from defining scope to setting up your first project for success.

Link in comments 👇

If you're evaluating CROs right now (or want a second set of eyes on an active project), drop me a DM. Happy to do a quick gut-check call.

---

Philip, please review both pieces and let me know:

1. Any edits to the blog post?

2. Approve the LinkedIn post as-is, or want Sonny to adjust the tone/CTA?

Once you approve, I'll be ready to publish the blog to Wix and you can post Sonny's version to LinkedIn!